GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » EV-to-Revenue

Hanmi Science Co (XKRX:008930) EV-to-Revenue : 1.96 (As of May. 06, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hanmi Science Co's enterprise value is ₩2,451,023 Mil. Hanmi Science Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,247,906 Mil. Therefore, Hanmi Science Co's EV-to-Revenue for today is 1.96.

The historical rank and industry rank for Hanmi Science Co's EV-to-Revenue or its related term are showing as below:

XKRX:008930' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.52   Med: 4.64   Max: 15.77
Current: 1.96

During the past 13 years, the highest EV-to-Revenue of Hanmi Science Co was 15.77. The lowest was 1.52. And the median was 4.64.

XKRX:008930's EV-to-Revenue is ranked worse than
78.35% of 97 companies
in the Medical Distribution industry
Industry Median: 0.6 vs XKRX:008930: 1.96

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-06), Hanmi Science Co's stock price is ₩33550.00. Hanmi Science Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩18,363.22. Therefore, Hanmi Science Co's PS Ratio for today is 1.83.


Hanmi Science Co EV-to-Revenue Historical Data

The historical data trend for Hanmi Science Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co EV-to-Revenue Chart

Hanmi Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.01 5.78 3.80 2.24 2.28

Hanmi Science Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.24 2.60 2.12 2.00 2.28

Competitive Comparison of Hanmi Science Co's EV-to-Revenue

For the Medical Distribution subindustry, Hanmi Science Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Science Co's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hanmi Science Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hanmi Science Co's EV-to-Revenue falls into.



Hanmi Science Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hanmi Science Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2451023.055/1247906.378
=1.96

Hanmi Science Co's current Enterprise Value is ₩2,451,023 Mil.
Hanmi Science Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,247,906 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Science Co  (XKRX:008930) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hanmi Science Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=33550.00/18363.219
=1.83

Hanmi Science Co's share price for today is ₩33550.00.
Hanmi Science Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩18,363.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Science Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hanmi Science Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Science Co (XKRX:008930) Business Description

Traded in Other Exchanges
N/A
Address
214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines